Your browser doesn't support javascript.
loading
Analysis of renal impairment in MM-003, a phase III study of pomalidomide + low - dose dexamethasone versus high - dose dexamethasone in refractory or relapsed and refractory multiple myeloma.
Weisel, Katja C; Dimopoulos, Meletios A; Moreau, Philippe; Lacy, Martha Q; Song, Kevin W; Delforge, Michel; Karlin, Lionel; Goldschmidt, Hartmut; Banos, Anne; Oriol, Albert; Alegre, Adrian; Chen, Christine; Cavo, Michele; Garderet, Laurent; Ivanova, Valentina; Martinez-Lopez, Joaquin; Knop, Stefan; Yu, Xin; Hong, Kevin; Sternas, Lars; Jacques, Christian; Zaki, Mohamed H; San Miguel, Jesus.
Afiliação
  • Weisel KC; Hematology and Oncology, Department of Medicine, University Hospital Tübingen, Germany katja.weisel@med.uni-tuebingen.de.
  • Dimopoulos MA; National and Kapodistrian University of Athens, Greece.
  • Moreau P; Hematology, University Hospital Hôtel-Dieu, Nantes, France.
  • Lacy MQ; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Song KW; Vancouver General Hospital, BC, Canada.
  • Delforge M; Department of Hematology, University Hospitals Leuven, Belgium.
  • Karlin L; Centre Hospitalier Lyon Sud/Hospices Civils de Lyon, Pierre-Bénite, France.
  • Goldschmidt H; Universitäts Klinikum Heidelberg, Germany.
  • Banos A; Hematology, Centre Hospitalier de la Côte Basque, Bayonne, France.
  • Oriol A; Institut Catala d'Oncologia, Hospital Germans Trias I Pujol, Barcelona, Spain.
  • Alegre A; Hospital Universitario La Princesa, Madrid, Spain.
  • Chen C; Princess Margaret Hospital, Toronto, ON, Canada.
  • Cavo M; Bologna University School of Medicine, Institute of Hematology and Medical Oncology, Bologna, Italy.
  • Garderet L; Hôpital Saint-Antoine, Paris, France.
  • Ivanova V; GUZ Moscow City Clinical Hospital S. P. Botkin, Moscow, Russia.
  • Martinez-Lopez J; Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Knop S; Hematology and Oncology, Würzburg University Medical Center, Würzburg, Germany.
  • Yu X; Celgene Corporation, Summit, NJ, USA.
  • Hong K; Celgene Corporation, Summit, NJ, USA.
  • Sternas L; Celgene Corporation, Summit, NJ, USA.
  • Jacques C; Celgene Corporation, Summit, NJ, USA.
  • Zaki MH; Celgene Corporation, Summit, NJ, USA.
  • San Miguel J; Clínica Universidad de Navarra, CIMA, IDISNA, Pamplona, Spain.
Haematologica ; 101(7): 872-8, 2016 07.
Article em En | MEDLINE | ID: mdl-27081177
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Insuficiência Renal / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Insuficiência Renal / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article